Anisotropine methylbromide and Prolymphocytic leukaemia - from FDA reports
There is no Prolymphocytic leukaemia reported by people who take Anisotropine methylbromide yet. This review analyzes which people have Prolymphocytic leukaemia with Anisotropine methylbromide. It is created by eHealthMe based on reports from FDA, and is updated regularly.
What to expect?
You are not alone!
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On May, 28, 2017
No report is found.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Do you have Prolymphocytic leukaemia when taking Anisotropine methylbromide?
- Check symptoms - is prolymphocytic leukaemia caused by a drug or a condition?
- Get alerts to symptoms - forecast your symptoms and get alerts
- Join related support groups - you are not alone, join a support group on ehealth.me
- Report the side effect - help people in need and in real time
- More tools...
Anisotropine methylbromide has active ingredients of anisotropine methylbromide. (latest outcomes from Anisotropine methylbromide 1 users)
Prolymphocytic leukaemia (cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells) has been reported by people with cytomegalovirus infection, prolymphocytic leukaemia, non-hodgkin's lymphoma, urinary tract infection, sepsis (latest reports from 84 Prolymphocytic leukaemia patients).